collection
MENU ▼
Read by QxMD icon Read
search

Heart broken kids and all causes of heart failure

shared collection
29 papers 0 to 25 followers
By Javier Castro Heart Failure And Heart Transplantation
https://www.readbyqxmd.com/read/27400984/drugs-that-may-cause-or-exacerbate-heart-failure-a-scientific-statement-from-the-american-heart-association
#1
Robert L Page, Cindy L O'Bryant, Davy Cheng, Tristan J Dow, Bonnie Ky, C Michael Stein, Anne P Spencer, Robin J Trupp, JoAnn Lindenfeld
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity, drug-drug interactions, or both. This scientific statement is designed to serve as a comprehensive and accessible source of drugs that may cause or exacerbate heart failure to assist healthcare providers in improving the quality of care for these patients...
August 9, 2016: Circulation
https://www.readbyqxmd.com/read/27372394/readmissions-for-heart-failure-in-children
#2
Brady S Moffett, Timothy J Humlicek, Joseph W Rossano, Jack F Price, Antonio G Cabrera
OBJECTIVE: To assess the frequency of inpatient 30-day readmission for heart failure in children with cardiomyopathy discharged after an admission for heart failure and the impact of discharge pharmacotherapy on readmissions. STUDY DESIGN: The Pediatric Health Information System Database was queried for patients ≤18 years of age with an International Classification of Diseases, Ninth Revision code for heart failure (428.xx) or cardiomyopathy (425.xx) discharged from 2004 to 2013...
October 2016: Journal of Pediatrics
https://www.readbyqxmd.com/read/26895877/-nihilism-of-chronic-heart-failure-therapy-in-children-and-why-effective-therapy-is-withheld
#3
REVIEW
Dietmar Schranz, Norbert F Voelkel
UNLABELLED: Major advances in chronic heart failure (cHF) therapy have been achieved and documented in adult patients, while research regarding the mechanisms and therapy of cHF in children has lagged behind. Based on receptor physiological studies and pharmacological knowledge, treatment with specific ß1-adrenergic receptor blocker (ARB), tissue angiotensin-converting enzyme inhibitor (ACE-I), and mineralocorticoid antagonists have to be recommended in children despite lack of sufficient data derived from prospective randomized studies...
April 2016: European Journal of Pediatrics
https://www.readbyqxmd.com/read/27289406/cardiopulmonary-exercise-testing-in-heart-failure
#4
REVIEW
Rajeev Malhotra, Kristian Bakken, Emilia D'Elia, Gregory D Lewis
Exercise intolerance, indicated by dyspnea and fatigue during exertion, is a cardinal manifestation of heart failure (HF). Cardiopulmonary exercise testing (CPET) precisely defines maximum exercise capacity through measurement of peak oxygen uptake (VO2). Peak VO2 values have a critical role in informing patient selection for advanced HF interventions such as heart transplantation and ventricular assist devices. Oxygen uptake and ventilatory patterns obtained during the submaximal portion of CPET are also valuable to recognize because of their ease of ascertainment during low-level exercise, relevance to ability to perform activities of daily living, independence from volitional effort, and strong relationship to prognosis in HF...
August 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27289293/usefulness-of-electrocardiographic-patterns-at-presentation-to-predict-long-term-risk-of-cardiac-death-in-patients-with-hypertrophic-cardiomyopathy
#5
Elena Biagini, Chiara Pazzi, Iacopo Olivotto, Beatrice Musumeci, Giuseppe Limongelli, Giuseppe Boriani, Giuseppe Pacileo, Vittoria Mastromarino, Maria Letizia Bacchi Reggiani, Massimiliano Lorenzini, Francesco Lai, Alessandra Berardini, Francesca Mingardi, Stefania Rosmini, Elvira Resciniti, Claudia Borghi, Camillo Autore, Franco Cecchi, Claudio Rapezzi
The objective of this study was to investigate the prognostic significance of 12-lead electrocardiogram (ECG) patterns in a large multicenter cohort of patients with hypertrophic cardiomyopathy; 1,004 consecutive patients with hypertrophic cardiomyopathy and a recorded standard ECG (64% men, mean age 50 ± 16 years) were evaluated at 4 Italian centers. The study end points were sudden cardiac death (SCD) or surrogates, including appropriate implanted cardiac defibrillator discharge and resuscitated cardiac arrest and major cardiovascular events (including SCD or surrogates and death due to heart failure, cardioembolic stroke, or heart transplantation)...
August 1, 2016: American Journal of Cardiology
https://www.readbyqxmd.com/read/26939781/drug-treatment-of-heart-failure-in-children-focus-on-recent-recommendations-from-the-ishlt-guidelines-for-the-management-of-pediatric-heart-failure
#6
Alexander D Hussey, Robert G Weintraub
The International Society of Heart and Lung Transplantation (ISHLT) recently updated consensus pediatric heart failure guidelines from those published in 2004 with an aim to provide a practical evidence-based resource whilst recognizing the influence of adult heart failure practice. The new guidelines were formed from published evidence for heart failure management and used parallels with adult literature where pediatric evidence was lacking. This is a summary of the pharmacological therapies discussed in the new 2014 guidelines, emphasizing changes from the previous recommendations with regards to treatment of chronic heart failure with reduced ejection fraction, chronic heart failure with preserved ejection fraction, and acute decompensated heart failure...
April 2016: Paediatric Drugs
https://www.readbyqxmd.com/read/26719183/dopamine-increases-mortality-in-pediatric-septic-shock
#7
COMMENT
Paul E Marik
No abstract text is available yet for this article.
January 2016: Journal of Pediatrics
https://www.readbyqxmd.com/read/26775029/chronic-heart-failure-ca-2-catabolism-and-catastrophic-cell-death
#8
REVIEW
Geoffrey W Cho, Francisco Altamirano, Joseph A Hill
Robust successes have been achieved in recent years in conquering the acutely lethal manifestations of heart disease. Many patients who previously would have died now survive to enjoy happy and productive lives. Nevertheless, the devastating impact of heart disease continues unabated, as the spectrum of disease has evolved with new manifestations. In light of this ever-evolving challenge, insights that culminate in novel therapeutic targets are urgently needed. Here, we review fundamental mechanisms of heart failure, both with reduced (HFrEF) and preserved (HFpEF) ejection fraction...
April 2016: Biochimica et Biophysica Acta
https://www.readbyqxmd.com/read/26718233/what-do-patients-with-hypertrophic-cardiomyopathy-die-from
#9
REVIEW
Barry J Maron, Ethan J Rowin, Susan A Casey, Ross F Garberich, Martin S Maron
Hypertrophic cardiomyopathy (HC) has become a contemporary and treatable genetic heart disease, now with disease-related mortality reduced to as low as 0.5% per year, based largely on more effective risk stratification and the use of the implantable cardioverter-defibrillator for primary prevention of sudden death. This paradigm change in the natural history of HC has caused us to reconsider the overall mortality risk in this disease. We interrogated the databases of 2 HC referral centers, Minneapolis Heart Institute and Tufts Medical Center...
February 1, 2016: American Journal of Cardiology
https://www.readbyqxmd.com/read/26717911/reliability-of-left-ventricular-hypertrophy-by-ecg-criteria-in-children-with-syncope-do-the-criteria-need-to-be-revised
#10
Maalika M Banerjee, V Ramesh Iyer, Deipanjan Nandi, Victoria L Vetter, Anirban Banerjee
In the outpatient setting, children who present with syncope routinely undergo electrocardiograms (ECG). Because of concerns for hypertrophic cardiomyopathy, children with syncope meeting ECG criteria for left ventricular hypertrophy (LVH) will frequently undergo an echocardiogram. Our objectives were to determine whether Davignon criteria for ECG waves overestimate LVH in children presenting with syncope, and to study the usefulness of echocardiography in these children. We hypothesize that the Davignon criteria presently used for interpretation of ECGs overestimate LVH, resulting in unnecessary echocardiography in this clinical setting...
April 2016: Pediatric Cardiology
https://www.readbyqxmd.com/read/26685073/assessment-of-quality-of-life-in-young-patients-with-single-ventricle-after-the-fontan-operation
#11
MULTICENTER STUDY
Karen Uzark, Victor Zak, Peter Shrader, Brian W McCrindle, Elizabeth Radojewski, James W Varni, Kaitlyn Daniels, Jill Handisides, Kevin D Hill, Linda M Lambert, Renee Margossian, Victoria L Pemberton, Wyman W Lai, Andrew M Atz
OBJECTIVES: To assess self-reported quality of life (QOL) in a large multicenter cohort of adolescent and young adults surviving Fontan. STUDY DESIGN: Cross-sectional. The Pediatric Quality of Life Inventory (PedsQL) was administered to 408 survivors of Fontan ages 13-25 years enrolled in the Pediatric Heart Network Fontan Follow-up Study. Subjects also completed either the Child Health Questionnaire (age <19 years) or Short Form Health Survey (age ≥ 19 years)...
March 2016: Journal of Pediatrics
https://www.readbyqxmd.com/read/26585035/acute-kidney-injury-in-pediatric-heart-failure
#12
REVIEW
Alyssa Riley, Daniel J Gebhard, Ayse Akcan-Arikan
Acute kidney injury (AKI) is very common in pediatric medical and surgical cardiac patients. Not only is it an independent risk factor for increased morbidity and mortality in the short run, but repeated episodes of AKI lead to chronic kidney disease (CKD) especially in the most vulnerable hosts with multiple risk factors, such as heart transplant recipients. The cardiorenal syndrome, a term coined to emphasize the bidirectional nature of simultaneous or sequential cardiac-renal dysfunction both in acute and chronic settings, has been recently described in adults but scarcely reported in children...
2016: Current Cardiology Reviews
https://www.readbyqxmd.com/read/26510399/endomyocardial-biopsy-safety-and-clinical-yield-in-pediatric-myocarditis-an-italian-perspective
#13
Maurizio Brighenti, Andrea Donti, Maria Giulia Gagliardi, Nicola Maschietto, Davide Marini, Maristella Lombardi, Ugo Vairo, Gabriella Agnoletti, Ornella Milanesi, Giacomo Pongiglione, Marco Bonvicini
OBJECTIVES: The objective of this investigation is to evaluate the safety, the impact of endomyocardial biopsy (EMB) results in myocarditis management and the incidence of different etiologies of myocarditis in a pediatric population. BACKGROUND: Although EMB is an established diagnostic tool to evaluate suspected myocarditis, there is lack of clear diagnostic and management guidelines for myocarditis in pediatric patients, particularly in infants. METHODS: We performed a retrospective database review and subsequent outcomes analysis from five Italian pediatric cardiology centers to identify patients aged 0-18 years who underwent EMB for suspected myocarditis or inflammatory cardiomyopathy (ICMP) between 2009 and 2011...
March 2016: Catheterization and Cardiovascular Interventions
https://www.readbyqxmd.com/read/26194549/viral-myocarditis-diagnosis-treatment-options-and-current-controversies
#14
REVIEW
Ari Pollack, Amy R Kontorovich, Valentin Fuster, G William Dec
Myocarditis--a frequent cause of dilated cardiomyopathy and sudden cardiac death--typically results from cardiotropic viral infection followed by active inflammatory destruction of the myocardium. Characterization of this disease has been hampered by its heterogeneous clinical presentations and diverse aetiologies. Advances in cardiac MRI and molecular detection of viruses by endomyocardial biopsy have improved our ability to diagnose and understand the pathophysiological mechanisms of this elusive disease...
November 2015: Nature Reviews. Cardiology
https://www.readbyqxmd.com/read/26197653/myocarditis-and-pericarditis-in-the-pediatric-patient-validated-management-strategies
#15
REVIEW
Kelly R Bergmann, Anupam Kharbanda, Lauren Haveman
Myocarditis and pericarditis are inflammatory conditions of the heart commonly caused by viral and autoimmune etiologies, although many cases are idiopathic. Emergency clinicians must maintain a high index of suspicion for these conditions, given the rarity and often nonspecific presentation in the pediatric population. Children with myocarditis may present with a variety of symptoms, ranging from mild flu-like symptoms to overt heart failure and shock, whereas children with pericarditis typically present with chest pain and fever...
July 2015: Pediatric Emergency Medicine Practice
https://www.readbyqxmd.com/read/26241540/124-cases-of-clinical-analysis-of-children-with-viral-myocarditis
#16
L Niu, X-J An, J Tian, Y Wang
OBJECTIVE: A study on clinical characteristics, diagnostic methods of children's viral myocarditis (VMC) and analysis of the effect of VMC is carried out. PATIENTS AND METHODS: A retrospective analysis of the clinical data of 124 cases of children with VMC from January 2008 to March 2011 in Xuzhou Children's Hospital is conducted. RESULTS: The age of onset of 1 VMC is less than 1 year old with the majority, fever, precordial pain, and fatigue as the main manifestation, auxiliary examination of abnormal electrocardiogram (ECG) in 110 cases, accounting for 88...
August 2015: European Review for Medical and Pharmacological Sciences
https://www.readbyqxmd.com/read/26300915/multimodality-imaging-in-cardiooncology
#17
REVIEW
Fausto Pizzino, Giampiero Vizzari, Rubina Qamar, Charles Bomzer, Scipione Carerj, Concetta Zito, Bijoy K Khandheria
Cardiotoxicity represents a rising problem influencing prognosis and quality of life of chemotherapy-treated patients. Anthracyclines and trastuzumab are the drugs most commonly associated with development of a cardiotoxic effect. Heart failure, myocardial ischemia, hypertension, myocarditis, and thrombosis are typical manifestation of cardiotoxicity by chemotherapeutic agents. Diagnosis and monitoring of cardiac side-effects of cancer treatment is of paramount importance. Echocardiography and nuclear medicine methods are widely used in clinical practice and left ventricular ejection fraction is the most important parameter to asses myocardial damage secondary to chemotherapy...
2015: Journal of Oncology
https://www.readbyqxmd.com/read/26327955/patterns-and-clinical-manifestations-of-tuberculous-myocarditis-a-systematic-review-of-cases
#18
REVIEW
Brian Nyasani Michira, Faraj Omar Alkizim, Duncan Mwangangi Matheka
Tuberculosis is a rare cause of myocarditis. It is however associated with a high mortality when it occurs and is often diagnosed at post-mortem. Tuberculous myocarditis prevalence in males is twice that in females. Most of the reported cases of tuberculous myocarditis are predominantly in immunocompetent patients. Out of the reported fatalities (sudden cardiac deaths), eighty one percent (81%) occur in the 'young' patients (below 45years). Antituberculosis drug therapy does not appear to offer mortality benefit against sudden cardiac deaths...
2015: Pan African Medical Journal
https://www.readbyqxmd.com/read/26347043/a-case-of-sudden-infant-death-due-to-incomplete-kawasaki-disease
#19
Daisuke Yajima, Keiko Shimizu, Kumiko Oka, Masaru Asari, Chikatoshi Maseda, Katsuhiro Okuda, Hiroshi Shiono, Seiji Ohtani, Katsuhiro Ogawa
Although Kawasaki disease (KD) is a self-limiting disease, it may cause sudden cardiac death. Diagnosis of KD is principally based on clinical signs; however, some infant cases do not meet the criteria. Such cases are identified as incomplete KD. The sudden death risk in incomplete KD cases is similar to conventional KD. In our 5-month-old case, he had been admitted to a hospital for a fever and suppuration at the site of Bacille de Calmette et Guerin (BCG) vaccination. However, after discharge from the hospital, his C-reactive protein (CRP) levels declined, he got indisposed and died suddenly...
January 2016: Journal of Forensic Sciences
https://www.readbyqxmd.com/read/26377721/lessons-learned-from-the-pediatric-cardiomyopathy-registry-pcmr-study-group
#20
REVIEW
James D Wilkinson, Joslyn A Westphal, Neha Bansal, Jason D Czachor, Hiedy Razoky, Steven E Lipshultz
Cardiomyopathy is a rare disorder of the heart muscle, affecting 1.13 cases per 100,000 children, from birth to 18 years of age. Cardiomyopathy is the leading cause of heart transplantation in children over the age of 1. The Pediatric Cardiomyopathy Registry funded in 1994 by the National Heart, Lung, and Blood Institute was established to examine the epidemiology of the disease in children below 18 years of age. More than 3500 children across the United States and Canada have been enrolled in the Pediatric Cardiomyopathy Registry, which has followed-up these patients until death, heart transplantation, or loss to follow-up...
August 2015: Cardiology in the Young
label_collection
label_collection
4922
1
2
2015-09-22 11:16:55
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"